Atlas Trials

Prospective Study on the Vaccine Response to Meningococcal B Vaccine After Allogeneic Stem Cell Transplantation

Clinical trial NCT03509051 · COMPLETED

Trial details

NCT number
NCT03509051
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hematopoietic Stem Cell TransplantMeningococcal Vaccine
Start date
2019-06-01
Primary completion
2020-03-13
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.